About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact Report
Caring for patients with cancer and rare diseases.
Personalized patient care has long been regarded as fundamental to quality healthcare. Tailoring treatment to the individual not only boosts the morale of patients confronting difficult diagnoses, but also significantly enhances health outcomes.
For over three decades, Biologics by McKesson has been dedicated to delivering care to meet each patient's needs. We specialize in cancer and rare disease areas with the goal of simplifying access to therapies and delivering personalized care to help patients understand how to take their medication, manage side effects and achieve the best possible outcomes.
We specialize in:
Improving the connection between providers and patients.
2.5M+
We supported over 2.5 million dispenses for patients across the U.S., Puerto Rico and Guam. ¹
$100M
Financial assistance opportunities identified for patients. ²
95%
Over 95% of Biologics dispenses had an out-of-pocket payment of $50 or less. ²
20K+
We maintain 20,000+ active provider relationships ³
200+
We offer more than 200 oncology and rare disease therapies.
25+
We have 25+ therapies exclusive to Biologics patients.
By connecting data-driven insights with deep therapeutic expertise, we help biopharma and community providers navigate complexity and bring state-of-the-art care closer to home.
Discover how InspiroGene by 51Âþ»appis collaborating with Biologics by 51Âþ»appto streamline cell and gene therapy delivery and accelerate patient access to treatments.
At Biologics by McKesson, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
Over three decades, Biologics by 51Âþ»appenhances medication access and personalized patient support.
Pharmacists diversify healthcare with their versatile expertise and unwavering commitment to patient well-being.
51Âþ»appis uniquely positioned to advance cancer care.
When Karen was diagnosed with ovarian cancer in 2008, Biologics by 51Âþ»appwas there to help put her mind at ease.
We walk alongside our patients, providing specialty drugs for diseases that are complex and require extra care. We also help patients understand how to thrive with these specialty medications.
We help our biopharma partners develop innovative, customized solutions and therapy-specific launch strategies to deliver exceptional results.
¹ Based on cumulative Biologics by 51Âþ»appdispense data from 2011–2025.
² Based on Biologics by 51Âþ»appdata for calendar year 2025.
³ Based on current Biologics by 51Âþ»appprovider relationship data.